Mesa Laboratories is a scientific & technical instruments business based in the US. Mesa Laboratories shares (MLAB) are listed on the NASDAQ and all prices are listed in US Dollars. Mesa Laboratories employs 698 staff and has a trailing 12-month revenue of around $219.3 million.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $112.94 |
|---|---|
| 52-week range | $113.72 - $205.68 |
| 50-day moving average | $131.42 |
| 200-day moving average | $156.77 |
| Wall St. target price | $152.50 |
| PE ratio | 349.6177 |
| Dividend yield | $0.64 (0.54%) |
| Earnings per share (TTM) | $0.34 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $112.94 from 2023-09-22
| 1 week (2023-09-15) | -8.11% |
|---|---|
| 1 month (2023-08-24) | -18.40% |
| 3 months (2023-06-23) | -11.14% |
| 6 months (2023-03-24) | -33.90% |
| 1 year (2022-09-23) | -19.84% |
|---|---|
| 2 years (2021-09-24) | -64.61% |
| 3 years (2020-09-24) | 240.1225 |
| 5 years (2018-09-24) | 181.9727 |
Valuing Mesa Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mesa Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $219.3 million |
|---|---|
| Operating margin TTM | 3.31% |
| Gross profit TTM | $116.6 million |
| Return on assets TTM | 0.68% |
| Return on equity TTM | 0.47% |
| Profit margin | 0.83% |
| Book value | $72.01 |
| Market Capitalization | $640 million |
TTM: trailing 12 months
Dividend payout ratio: 1.94% of net profits
Recently Mesa Laboratories has paid out, on average, around 1.94% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.54% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Mesa Laboratories shareholders could enjoy a 0.54% return on their shares, in the form of dividend payments. In Mesa Laboratories's case, that would currently equate to about $0.64 per share.
While Mesa Laboratories's payout ratio might seem low, this can signify that Mesa Laboratories is investing more in its future growth.
Mesa Laboratories's most recent dividend payout was on 14 September 2023. The latest dividend was paid out to all shareholders who bought their shares by 29 August 2023 (the "ex-dividend date").
Over the last 12 months, Mesa Laboratories's shares have ranged in value from as little as $113.7227 up to $205.6825. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mesa Laboratories's is 0.7192. This would suggest that Mesa Laboratories's shares are less volatile than average (for this exchange).
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions.
Everything we know about the Discord IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.